Home/Filings/4/0001209191-18-007242
4//SEC Filing

Beer Marc D 4

Accession 0001209191-18-007242

CIK 0001598646other

Filed

Feb 1, 7:00 PM ET

Accepted

Feb 2, 8:02 PM ET

Size

26.9 KB

Accession

0001209191-18-007242

Insider Transaction Report

Form 4
Period: 2018-01-31
Beer Marc D
Director
Transactions
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2018-01-31127,5130 total
    Exercise: $6.00Exp: 2024-06-29Common Stock (127,513 underlying)
  • Award

    Stock Option (Right to Buy)

    2018-01-31+12,50012,500 total
    Exercise: $10.20Exp: 2020-01-31Common Stock (12,500 underlying)
  • Award

    Stock Option (Right to Buy)

    2018-01-31+12,50012,500 total
    Exercise: $10.00Exp: 2020-01-31Common Stock (12,500 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2018-01-3180,3560 total
    Exercise: $9.49Exp: 2023-12-19Common Stock (80,356 underlying)
  • Award

    Stock Option (Right to Buy)

    2018-01-31+127,513127,513 total
    Exercise: $6.00Exp: 2020-01-31Common Stock (127,513 underlying)
  • Award

    Stock Option (Right to Buy)

    2018-01-31+80,35680,356 total
    Exercise: $9.49Exp: 2020-01-31Common Stock (80,356 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2018-01-317,5000 total
    Exercise: $4.34Exp: 2025-02-01Common Stock (7,500 underlying)
  • Award

    Stock Option (Right to Buy)

    2018-01-31+7,5007,500 total
    Exercise: $4.34Exp: 2020-01-31Common Stock (7,500 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2018-01-3112,5000 total
    Exercise: $10.20Exp: 2026-06-15Common Stock (12,500 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2018-01-3112,5000 total
    Exercise: $10.00Exp: 2027-05-31Common Stock (12,500 underlying)
Footnotes (5)
  • [F1]The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on December 20, 2013 and is fully vested.
  • [F2]The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on June 30, 2014 and is fully vested.
  • [F3]The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on February 2, 2015 and is fully vested.
  • [F4]The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on June 16, 2016 and is fully vested.
  • [F5]The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on June 1, 2017 and provides for vesting in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 1, 2017 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date.

Issuer

Minerva Neurosciences, Inc.

CIK 0001598646

Entity typeother

Related Parties

1
  • filerCIK 0001314575

Filing Metadata

Form type
4
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 8:02 PM ET
Size
26.9 KB